Kathleen Gustafson, Ph.D.

Research Assistant Professor


Dr. Gustafson was awarded a Ph.D. in Visual Electrophysiology in 1994 for describing abnormalities in retinal signal processing in human subjects with Duchenne muscular dystrophy and mouse models with dystrophin mutations. This work led to the co-discovery of a new dystrophin isoform found only in retina (Dp260).

Prior to joining the Hoglund Brain Imaging Center, she was the Director of the Vision Science Laboratory at The Children's Mercy Hospital and Assistant Professor of Rehabilitative Medicine, University of Missouri School of Medicine for 19 years. She is the Associate Director of the fetal MEG program and is also responsible for research investigations related to Vision Science. She holds 2 patents for her contribution to the discovery of human retinal dystrophin and 2 patents for her involvement in a multi-center trial that showed the nutritional content of a new premature infant formula was essential for optimal infant visual development.

Dr. Gustafson has published 27 peer-reviewed journal articles, co-authored 3 book chapters and is currently the principal investigator of a clinical trial investigating the effects of DHA supplementation during pregnancy on maternal, fetal and infant cardiac autonomic control and newborn neurobehavior.

Last modified: Feb 26, 2014

Kathleen Gustafson, Ph.D.

Contact

Kathleen Gustafson, Ph.D.
Research Assistant Professor

ID=x658